Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6810)
All Articles published online
|
Mar 27, 2010 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sukowati CH, Rosso N, Crocè LS, Tiribelli C. Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma. World J Hepatol 2010; 2(3): 114-126 [PMID: 21160982 DOI: 10.4254/wjh.v2.i3.114] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v2/i3/114.htm |
| Number | Citing Articles |
| 1 |
Ryouichi Tsunedomi, Kiyoshi Yoshimura, Yuta Kimura, Mitsuo Nishiyama, Nobuyuki Fujiwara, Satoshi Matsukuma, Shinsuke Kanekiyo, Hiroto Matsui, Yoshitaro Shindo, Yusaku Watanabe, Yukio Tokumitsu, Shin Yoshida, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, Tatsuya Ioka, Shoichi Hazama, Hiroaki Nagano. Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09370-1
|
| 2 |
Zhao Yang, Shengwu Liu, Mingao Zhu, Hong Zhang, Ji Wang, Qian Xu, Kaisu Lin, Xiumin Zhou, Min Tao, Chong Li, Hong Zhu. PS341 inhibits hepatocellular and colorectal cancer cells through the FOXO3/CTNNB1 signaling pathway. Scientific Reports 2016; 6(1) doi: 10.1038/srep22090
|
| 3 |
Chun-Yen Liu, Chang-Hung Hsieh, Seung-Hun Kim, Jing-Ping Wang, Yu-Lin Ni, Chun-Li Su, Ching-Fa Yao, Kang Fang. An indolylquinoline derivative activates DNA damage response and apoptosis in human hepatocellular carcinoma cells. International Journal of Oncology 2016; 49(6): 2431 doi: 10.3892/ijo.2016.3717
|
| 4 |
Basant M. Salama, Maged W. Helmy, Hosny Fouad, Marium M. Shamaa, Maha E. Houssen. The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy–Apoptosis Molecular Crosstalk. Current Issues in Molecular Biology 2023; 45(7): 5935 doi: 10.3390/cimb45070375
|
| 5 |
Rahul Kumar Vempati, Rama Rao Malla. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 63 doi: 10.1016/B978-0-323-99283-1.00012-4
|
| 6 |
Hao Ding, Yijun Wang, Hongying Zhang. CCND1 silencing suppresses liver cancer stem cell differentiation and overcomes 5-Fluorouracil resistance in hepatocellular carcinoma. Journal of Pharmacological Sciences 2020; 143(3): 219 doi: 10.1016/j.jphs.2020.04.006
|
| 7 |
Nadzifa Nugraheni, Ummi Maryam Zulfin, Beni Lestari, Novia Permata Hapsari, Muthi Ikawati, Rohmad Yudi Utomo, Yusuke Suenaga, Yoshitaka Hippo, Edy Meiyanto. PGV-1 Causes Disarrangement of Spindle Microtubule Organization Resulting in Aberrant Mitosis in HLF and HuH6 Cells Associated with Altered MYCN Status. Advanced Pharmaceutical Bulletin 2024; 14(3): 665 doi: 10.34172/apb.2024.058
|
| 8 |
Yijie Zhang, Qi Pan, Zigong Shao. Extracellular vesicles derived from cancer-associated fibroblasts carry tumor-promotive microRNA-1228-3p to enhance the resistance of hepatocellular carcinoma cells to sorafenib. Human Cell 2022; 36(1): 296 doi: 10.1007/s13577-022-00800-7
|
| 9 |
Hua Yang, Guojun Zhai, Xiaoxu Ji, Jing Su, Ming Lin. Reduced Expression of Argininosuccinate Lyase is Closely Associated With Postresectional Survival in Hepatocellular Carcinoma. Applied Immunohistochemistry & Molecular Morphology 2012; 20(6): 602 doi: 10.1097/PAI.0b013e318250c814
|
| 10 |
Cholpajsorn Junhom, Natthida Weerapreeyakul, Waraporn Tanthanuch, Kanjana Thumanu. FTIR microspectroscopy defines early drug resistant human hepatocellular carcinoma (HepG2) cells. Experimental Cell Research 2016; 340(1): 71 doi: 10.1016/j.yexcr.2015.12.007
|
| 11 |
Bo-Han Zhang, Jian Yang, Li Jiang, Tao Lyu, Ling-Xiang Kong, Yi-Fei Tan, Bo Li, Yun-Feng Zhu, Ao-Yao Xi, Xi Xu, Lyu-Nan Yan, Jia-Yin Yang. Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma. Genomics 2020; 112(4): 2763 doi: 10.1016/j.ygeno.2020.03.013
|
| 12 |
Jia-Jie Chen, Nan Cai, Guan-Zhong Chen, Chang-Chang Jia, Dong-Bo Qiu, Cong Du, Wei Liu, Yang Yang, Zi-Jie Long, Qi Zhang. The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma. Oncotarget 2017; 8(11): 17593 doi: 10.18632/oncotarget.4307
|
| 13 |
Jun Ho Lee, Jae Hee Suh, Hyun Je Kang, Soo Youn Choi, Seok Won Jung, Whaseon Lee-Kwon, Soo-Ah Park, Hajin Kim, Byeong Jin Ye, Eun Jin Yoo, Gyu Won Jeong, Neung Hwa Park, Hyug Moo Kwon. Tonicity-responsive enhancer-binding protein promotes stemness of liver cancer and cisplatin resistance. EBioMedicine 2020; 58: 102926 doi: 10.1016/j.ebiom.2020.102926
|
| 14 |
Guan-Yu Chen, Duo Wang. Prognostic Value of Macrophage-Associated Long Non-Coding RNA Expression for Hepatocellular Carcinoma. Cancer Management and Research 2022; : 215 doi: 10.2147/CMAR.S340574
|
| 15 |
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, Stavroula Baritaki. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability. Drug Resistance Updates 2022; 65: 100866 doi: 10.1016/j.drup.2022.100866
|
| 16 |
Wendy W. Bautista, Carla Osiowy, Julianne Klein, Gerald Y. Minuk. Hepatitis B Virus Infection of Normal Hepatic Stem/Progenitor Cells. Journal of Clinical and Experimental Hepatology 2019; 9(1): 34 doi: 10.1016/j.jceh.2018.02.002
|
| 17 |
Jina Lee, Ji-Soo Kim, Hye-In Cho, So-Ra Jo, Yeun-Kyu Jang. JIB-04, a Pan-Inhibitor of Histone Demethylases, Targets Histone-Lysine-Demethylase-Dependent AKT Pathway, Leading to Cell Cycle Arrest and Inhibition of Cancer Stem-Like Cell Properties in Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences 2022; 23(14): 7657 doi: 10.3390/ijms23147657
|
| 18 |
Aswathy R. Devan, Ayana R. Kumar, Bhagyalakshmi Nair, Nikhil Ponnoor Anto, Amitha Muraleedharan, Bijo Mathew, Hoon Kim, Lekshmi R. Nath. Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma. Pharmaceuticals 2021; 14(7): 656 doi: 10.3390/ph14070656
|
| 19 |
Nahed Abdel-Aziz, Sawsan M. El-Sonbaty, Marwa G. A. Hegazy. Ameliorative potential of manganese nanoparticles with low-level ionizing radiation against experimentally induced hepatocarcinogenesis. Environmental Science and Pollution Research 2021; 28(46): 65474 doi: 10.1007/s11356-021-15571-1
|
| 20 |
Retraction. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 319(5): G638 doi: 10.1152/ajpgi.00042.2020
|
| 21 |
YI-DEUN JUNG, JAE-WOONG SHIM, SEONG-JOON PARK, SI HO CHOI, KWANGMO YANG, KYU HEO, MOON-TAEK PARK. Downregulation of UHRF1 promotes EMT via inducing CXCR4 in human cancer cells. International Journal of Oncology 2015; 46(3): 1232 doi: 10.3892/ijo.2014.2813
|
| 22 |
Noriaki Hashimoto, Ryouichi Tsunedomi, Kiyoshi Yoshimura, Yusaku Watanabe, Shoichi Hazama, Masaaki Oka. Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-722
|
| 23 |
Korawith Srisa-nga, Samlee Mankhetkorn, Siriporn Okonogi, Ruttiros Khonkarn. Delivery of Superparamagnetic Polymeric Micelles Loaded With Quercetin to Hepatocellular Carcinoma Cells. Journal of Pharmaceutical Sciences 2019; 108(2): 996 doi: 10.1016/j.xphs.2018.08.008
|
| 24 |
Chun‑Lin Gao, Gao‑Wei Wang, Guan‑Qin Yang, Hong Yang, Li Zhuang. Karyopherin subunit-α 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma. Oncology Letters 2017; doi: 10.3892/ol.2017.7691
|
| 25 |
Margherita Correnti, Chiara Raggi. Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer. Oncotarget 2017; 8(4): 7094 doi: 10.18632/oncotarget.12569
|
| 26 |
Hongzhi Wang, Satheesh Ellipilli, Wen-Jui Lee, Xin Li, Mario Vieweger, Yuan-Soon Ho, Peixuan Guo. Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance. Journal of Controlled Release 2021; 330: 173 doi: 10.1016/j.jconrel.2020.12.007
|
| 27 |
Shafinaz Abd Gani, Suleiman Alhaji Muhammad, Aminu Umar Kura, Farahnaz Barahuie, Mohd Zobir Hussein, Sharida Fakurazi, Salah A. Sheweita. Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine/phenobarbital-induced hepatocellular carcinoma in mice. PLOS ONE 2019; 14(5): e0217009 doi: 10.1371/journal.pone.0217009
|
| 28 |
Grégory Fouquet, Constance Marié, Louison Collet, Catherine Vilpoux, Hakim Ouled-Haddou, Eric Nguyen-Khac, Jagadeesh Bayry, Mickaël Naassila, Ingrid Marcq, Hicham Bouhlal. Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition. Cancers 2022; 14(4): 910 doi: 10.3390/cancers14040910
|
| 29 |
G.Y. Minuk, Y. Baruch. Hepatitis B viral infection of hepatic progenitor cells. Resolving unresolved questions?. Medical Hypotheses 2016; 91: 24 doi: 10.1016/j.mehy.2016.04.011
|
| 30 |
Anna Alisi, Georges Baffet. Self-Renewal of Tumor-Initiating Cells: What's New About Hepatocellular Carcinoma?. Gastroenterology 2012; 142(7): 1414 doi: 10.1053/j.gastro.2012.04.037
|
| 31 |
Ryouichi Tsunedomi, Kiyoshi Yoshimura, Nobuaki Suzuki, Shoichi Hazama, Hiroaki Nagano. Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact. Surgery Today 2020; 50(12): 1560 doi: 10.1007/s00595-020-01968-x
|
| 32 |
Katherine S. Koch, Hyam L. Leffert. Principles of Stem Cell Biology and Cancer. 2015; : 273 doi: 10.1002/9781118670613.ch14
|
| 33 |
Xuehua Liu, Junhua Zuo, Yuan Fang, Jing Wen, Feihong Deng, Hui Zhong, Bo Jiang, Jide Wang, Biao Nie. Downregulation of hepatic lipase is associated with decreased CD133 expression and clone formation in HepG2 cells. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3756
|
| 34 |
Jiarong Cao, Yan Zheng. iTRAQ-based quantitative proteomic analysis of the antimicrobial mechanism of lactobionic acid againstStaphylococcus aureus. Food & Function 2021; 12(3): 1349 doi: 10.1039/D0FO02491K
|
| 35 |
Hongxing Zhao, Yuhang Ling, Jie He, Jinling Dong, Qinliang Mo, Yao Wang, Ying Zhang, Hongbin Yu, Chengwu Tang. Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma. Drug Resistance Updates 2024; 74: 101084 doi: 10.1016/j.drup.2024.101084
|
| 36 |
Johanna K. DiStefano, Caecilia Sukowati. The Chemical Biology of Long Noncoding RNAs. RNA Technologies 2020; 11: 199 doi: 10.1007/978-3-030-44743-4_8
|
| 37 |
Lin Zhang, Hong Li, Chao Ge, Meng Li, Fang-yu Zhao, He-lei Hou, Miao-xin Zhu, Hua Tian, Li-xing Zhang, Tao-yang Chen, Guo-ping Jiang, Hai-yang Xie, Ying Cui, Ming Yao, Jin-jun Li. Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma. Oncotarget 2014; 5(21): 10621 doi: 10.18632/oncotarget.2524
|